Status and phase
Conditions
Treatments
About
The purpose of this study is to test the safety of high dose omeprazole and see what effects that it has on patients with exocrine pancreatic cancer.
Full description
During this study patients will receive treatment of omeprazole at the dose depending on group enrollment
Patients will receive treatment for 2~3 weeks during the study, and 2 months of follow up.
Total accrual is anticipated to take 2 years.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
60 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
SCC IIT Office; Ingrid Block
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal